INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 August 2015
|
Net Assets |
£238m |
|
Net Assets per share |
591p |
|
Share price |
551p |
|
Total value of unquoted investments |
£23m |
|
Total number of portfolio companies |
101 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
9.1 |
|
Gilead |
7.4 |
|
Regeneron |
7.1 |
|
Biogen |
5.1 |
|
Amgen |
4.9 |
|
Alexion |
4.6 |
|
Vertex |
3.9 |
|
Chimerix |
3.2 |
|
Incyte |
3.0 |
|
Biomarin |
3.0 |
|
|
----------- |
|
Total |
51.3 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
54 |
|
Turning Profitable 2015 |
8 |
|
Unprofitable |
38 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
81 |
|
Europe & UK |
19 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
91 |
|
Unquoted |
9 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
23 SEPTEMBER 2015